<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27078" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>PHACE Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chamli</surname>
            <given-names>Amal</given-names>
          </name>
          <aff>Charles Nicolle Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Litaiem</surname>
            <given-names>Noureddine</given-names>
          </name>
          <aff>University of Tunis El Manar</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amal Chamli declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Noureddine Litaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>6</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27078.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Infantile hemangioma is the most prevalent benign tumor of infancy, with an estimated incidence between 4 and 5 percent. Large facial segmental hemangioma is associated with PHACES syndrome, which is an acronym for posterior fossa malformations, hemangioma of the cervicofacial region, arterial anomalies, cardiac anomalies, eye anomalies, and sternal or abdominal clefting or ectopia cordis. This activity reviews the evaluation and management of PHACES syndrome and highlights the role of interprofessional team members in collaborating to provide well-coordinated care and enhance outcomes for affected patients.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline PHACES syndrome.</p></list-item><list-item><p>Explain when PHACES syndrome should be included on differential diagnosis.</p></list-item><list-item><p>Review the management of PHACES syndrome.</p></list-item><list-item><p>Describe the need for a well-integrated, interprofessional team approach to monitor development and identify any complications for patients with PHACES syndrome.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27078&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27078">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27078.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Infantile hemangioma is the most prevalent benign tumor of infancy. The estimated incidence is between 4% and 5%. Large facial segmental hemangioma has associations with PHACES syndrome (PS), which is an acronym for <bold>p</bold>osterior fossa malformations, <bold>h</bold>emangioma of the cervicofacial region, <bold>a</bold>rterial anomalies, <bold>c</bold>ardiac anomalies, <bold>e</bold>ye anomalies, and <bold>s</bold>ternal or abdominal clefting or ectopia cordis. It was first described in 1996 by Frieden and colleagues and named PHACE syndrome. After that, Boulinguez and colleagues changed the acronym to PHACES syndrome by adding sternal defects (S). PS is a rare congenital cervicofacial infantile hemangioma. It occurs in 2% of cases.<xref ref-type="bibr" rid="article-27078.r1">[1]</xref><xref ref-type="bibr" rid="article-27078.r2">[2]</xref> It is a neurocutaneous syndrome, characteristically demonstrating a segmental distribution usually involving the face, neck, and scalp, either as one lesion or many lesions. This rare congenital disease includes dermatological, cardiac, neurological, and ocular manifestations. The most common extracutaneous manifestations are the structural brain, cerebrovascular, and cardiovascular abnormalities.</p>
      </sec>
      <sec id="article-27078.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>PHACE syndrome is considered a non-hereditary condition. The etiology is not fully understood. Most cases are sporadic, but suggestions exist that it may correlate to a mutation in the X-linked genes since its female predominance, with prenatal male lethality.<xref ref-type="bibr" rid="article-27078.r3">[3]</xref> It corresponds with various genetic and phenotypic anomalies. Some authors suggest a developmental error between 6 and 8 weeks of gestation, before or during vasculogenesis.</p>
      </sec>
      <sec id="article-27078.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>PS is more prevalent in the White and Hispanic populations. There is a female predominance with a female-to-male ratio of 9 to 1.<xref ref-type="bibr" rid="article-27078.r1">[1]</xref>&#x000a0;Approximately 20 % of children with facial hemangioma will develop one of the abnormalities of PS.<xref ref-type="bibr" rid="article-27078.r4">[4]</xref>&#x000a0;The risk of extracutaneous abnormalities increases with increasing hemangioma size and when the hemangioma involves multiple facial segments.<xref ref-type="bibr" rid="article-27078.r5">[5]</xref></p>
      </sec>
      <sec id="article-27078.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The physiopathology of PHACE syndrome is different from that of isolated hemangioma. It is not fully understood and demonstrates no family inheritance pattern.</p>
        <p>The ipsilateral malformation in PS suggests an abnormal embryonic or fetal development.</p>
        <p>Also, the vascular abnormalities may result from regional arterial insufficiency and disruption of the normal arterial wall and, therefore, alteration in blood flow and hypoxia. Thus, these changes lead to the formation of hemangioma and abnormalities in brain structures.<xref ref-type="bibr" rid="article-27078.r3">[3]</xref></p>
      </sec>
      <sec id="article-27078.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>PHACE syndrome is a neurocutaneous disorder. Cutaneous anomalies are manifested by hemangioma, which can be absent, subtle at birth, or obvious after birth. It can be present at birth as premonitory lesions as an erythematous patch or a telangiectatic red macule. It is typically characterized by a large segmental cervicofacial hemangioma as red-bluish soft masses covering a broad cutaneous territory or manifests as confluent plaques or small individual papules clustered that assume a specific distribution. The pattern, in some cases, has a dermatomal involvement, occurring trigeminal patterns V1, V2, and V3 facial hemangioma is the most frequent localization. It can occur unilaterally or bilaterally. Lesions undergo a proliferative phase followed by slow involution often leading to complete regression. There are reports of a suspected link between the distribution of facial hemangioma and extracutaneous manifestations.</p>
        <p>The face is divided into four segments related to the prominences of facial develo&#x000ad;pment: frontotemporal (segment 1), maxillary (segment 2), mandibular (segment 3), and frontonasal (segment 4). Hemangiomas on the frontotemporal and frontonasal segments have been reported with a higher risk of ocular, cerebrovascular, and brain involvement, whereas those on the mandibular segment correlate with a potential risk of midline and cardiovascular defects. However, these correlations have not been fully elucidated.<xref ref-type="bibr" rid="article-27078.r6">[6]</xref></p>
        <p>Furthermore, the hemangioma may occur elsewhere in the body; the most common association is with the segmental hemangioma or the subglottic (airway hemangioma) and occasionally may be seen in the gastrointestinal tract.<xref ref-type="bibr" rid="article-27078.r7">[7]</xref></p>
        <p>The extracutaneous manifestations include abnormalities of the brain, cerebral vasculature, aorta, eyes, and chest wall. The most common associated extracutaneous findings are cerebrovascular (91%), cardiovascular (67%), and brain (52%) abnormalities. Thereon, the cerebrovascular involvement is typically related&#x000a0;to the ipsilateral internal carotid artery. &#x000a0;The most frequent cardiovascular abnormalities are aberrant subclavian artery and coarctation of the aorta, which are present in 20% of cases. Brain abnormalities mainly involve the posterior fossa and may include cerebral hypoplasia, cortical dysgenesis, and Danky-Walker malformation. Additionally, neurological symptoms are variable, depending on the associated territory of the occluded artery. The ophthalmologic manifestations include microphthalmia, glaucoma, and coloboma.<xref ref-type="bibr" rid="article-27078.r6">[6]</xref><xref ref-type="bibr" rid="article-27078.r8">[8]</xref><xref ref-type="bibr" rid="article-27078.r9">[9]</xref></p>
      </sec>
      <sec id="article-27078.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>PHACE syndrome should be suspected in the presence of cervicofacial infantile hemangioma over 5cm in size, and a systemic evaluation is required. Thus, history taking and careful physical examination are necessary. Imaging with magnetic resonance imaging (MRI) and/or magnetic resonance angiography (MRA) of the head and neck should be ordered if PS is suspected. Moreover, an ophthalmic evaluation should be performed to look for eye abnormalities associated with PS. Also, an echocardiogram should be performed, looking for heart and aortic abnormalities.</p>
        <p>PS can be suspected during pregnancy. Antenatal ultrasound screening can detect abnormalities of the posterior fossa, and therefore, an MRI is recommended to assess the diagnosis in the antenatal period.<xref ref-type="bibr" rid="article-27078.r10">[10]</xref> Additionally, an appropriate endocrinologic workup should be performed according to the clinical signs.</p>
        <p>An interprofessional group of specialists has established the 2009 diagnostic criteria, which had an update in 2016. The diagnostic basis of definite PS is the presence of a facial hemangioma of more than 5 cm with one major criterion or two minor criteria. Possible PS requires the presence of cervicofacial hemangioma with one minor criterion.<xref ref-type="bibr" rid="article-27078.r11">[11]</xref></p>
        <p>Major criteria:</p>
        <list list-type="bullet">
          <list-item>
            <p>Arterial: anomalies of major cerebral or cervical arteries, stenosis, occlusion, dysplasia, hypoplasia, persistent carotid-vertebrobasilar anastomosis</p>
          </list-item>
          <list-item>
            <p>Structural brain: posterior fossa anomalies: Danky-Walker complex, unilateral or bilateral cerebral dysplasia or hypoplasia</p>
          </list-item>
          <list-item>
            <p>Cardiovascular: aortic arch anomalies, aneurysm, an aberrant origin of the subclavian artery</p>
          </list-item>
          <list-item>
            <p>Ocular: posterior segment anomaly, retinal vascular anomalies</p>
          </list-item>
          <list-item>
            <p>Ventral or midline: sternal defect, sternal cleft</p>
          </list-item>
        </list>
        <p>Minor criteria:</p>
        <list list-type="bullet">
          <list-item>
            <p>Arterial: aneurysm of cerebral arteries</p>
          </list-item>
          <list-item>
            <p>Structural brain: midline anomaly, malformation of cortical development, neuronal migration disorder</p>
          </list-item>
          <list-item>
            <p>Cardiovascular: ventricular septal defect, right aortic arch</p>
          </list-item>
          <list-item>
            <p>Ocular: anterior segment anomalies, cataracts, sclerocornea, microphthalmia</p>
          </list-item>
          <list-item>
            <p>Ventral or midline: hypopituitarism, ectopic thyroid, midline sternal papule<xref ref-type="bibr" rid="article-27078.r11">[11]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27078.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The management should be multidisciplinary. There is no standardized treatment protocol for affected children. The treatment directs itself toward the specific symptoms in each patient. Patients with PS may need to be managed by cardiologists and neurologists, depending on their extracutaneous manifestations. The hemangioma is generally treated successfully with oral propranolol with caution because of the risk of stroke in patients with heart or blood vessel problems. Also, treatment of hemangioma may involve systemic steroids, surgery, or laser therapy. Therapy with aspirin is generally recommended to prevent ischemic accidents. Cardiovascular abnormalities may require early surgical intervention.<xref ref-type="bibr" rid="article-27078.r12">[12]</xref></p>
      </sec>
      <sec id="article-27078.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Sturge-Weber syndrome</p>
          </list-item>
          <list-item>
            <p>Infantile hemangioma</p>
          </list-item>
          <list-item>
            <p>Visceral hemangioma</p>
          </list-item>
          <list-item>
            <p>Wyburn-Mason syndrome</p>
          </list-item>
          <list-item>
            <p>LUMBAR syndrome<xref ref-type="bibr" rid="article-27078.r13">[13]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27078.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis is variable. It depends on the associated manifestations. Neurological and cognitive impairments are very common, and they constitute the most significant source of morbidity.</p>
      </sec>
      <sec id="article-27078.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Hemangioma: ulceration, bleeding, visual compromise, cause issues with vital function</p>
          </list-item>
          <list-item>
            <p>Cardiovascular: coarctation of the aorta is the most common (14,5 %); other aortic arch abnormalities</p>
          </list-item>
          <list-item>
            <p>Neurological: migraine headaches, developmental delays, seizures, speech delays, and rarely ischemic strokes or hemorrhage</p>
          </list-item>
          <list-item>
            <p>Ophthalmological: cataract, glaucoma</p>
          </list-item>
          <list-item>
            <p>Occasionally, dental hypoplasia, impaired hearing, and endocrine abnormalities (hypopituitarism and hypothyroidism)</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27078.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>PHACE syndrome is a rare neurocutaneous condition. It presents with anomalies involving different organ systems. It may have a potential psychosocial impact on the patient as well as the family. Thus, psychosocial support is essential for the entire family. Children with PS may experience a delay in attaining speech, swallowing dysfunction, and migraine headaches. Therefore, periodic screening is mandatory to detect language abnormalities, treat precociously, and prevent other complications.<xref ref-type="bibr" rid="article-27078.r14">[14]</xref></p>
      </sec>
      <sec id="article-27078.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Children with PS should receive an interprofessional approach, including a team of pediatric dermatologists, ophthalmologists, cardiac surgeons, cardiologists, sociologists, outpatient visiting nurses, and neurologists. Moreover, awareness of this entity and early diagnosis is important for appropriate treatment. Finally, PS requires a regular follow-up, particularly through the school-age period, to watch for complications and to monitor development.</p>
      </sec>
      <sec id="article-27078.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27078&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27078">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/child-health/phace-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=27078">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27078/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27078">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27078.s15">
        <title>References</title>
        <ref id="article-27078.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Castellano-Mart&#x000ed;nez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rodriguez-Gonzalez</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Benavente-Fernandez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Zuazo-Ojeda</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Hemangioma, aortic coarctation and intracranial dolichoectasia: PHACE syndrome.</article-title>
            <source>Pediatr Int</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>59</volume>
            <issue>2</issue>
            <fpage>230</fpage>
            <page-range>230-233</page-range>
            <pub-id pub-id-type="pmid">28211225</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bellaud</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Puzenat</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Billon-Grand</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Humbert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Aubin</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>PHACE syndrome, a series of six patients: clinical and morphological manifestations, propranolol efficacy, and safety.</article-title>
            <source>Int J Dermatol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>102</fpage>
            <page-range>102-7</page-range>
            <pub-id pub-id-type="pmid">24962639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Foster</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ares</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Tempel</surname>
                <given-names>ZJ</given-names>
              </name>
              <name>
                <surname>McCormick</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Panigrahy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Grunwaldt</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>PHACE syndrome is associated with intracranial cavernous malformations.</article-title>
            <source>Childs Nerv Syst</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>32</volume>
            <issue>8</issue>
            <fpage>1463</fpage>
            <page-range>1463-9</page-range>
            <pub-id pub-id-type="pmid">27125518</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hartemink</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Chiu</surname>
                <given-names>YE</given-names>
              </name>
              <name>
                <surname>Drolet</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Kerschner</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>PHACES syndrome: a review.</article-title>
            <source>Int J Pediatr Otorhinolaryngol</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>73</volume>
            <issue>2</issue>
            <fpage>181</fpage>
            <page-range>181-7</page-range>
            <pub-id pub-id-type="pmid">19101041</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Heyer</surname>
                <given-names>GL</given-names>
              </name>
            </person-group>
            <article-title>PHACE(S) syndrome.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2015</year>
            <volume>132</volume>
            <fpage>169</fpage>
            <page-range>169-83</page-range>
            <pub-id pub-id-type="pmid">26564079</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rotter</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Samorano</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Rivitti-Machado</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>ZNP</given-names>
              </name>
              <name>
                <surname>Gontijo</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>PHACE syndrome: clinical manifestations, diagnostic criteria, and management.</article-title>
            <source>An Bras Dermatol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>93</volume>
            <issue>3</issue>
            <fpage>405</fpage>
            <page-range>405-411</page-range>
            <pub-id pub-id-type="pmid">29924216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Boycott</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Dyment</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Innes</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Unsolved recognizable patterns of human malformation: Challenges and opportunities.</article-title>
            <source>Am J Med Genet C Semin Med Genet</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>178</volume>
            <issue>4</issue>
            <fpage>382</fpage>
            <page-range>382-386</page-range>
            <pub-id pub-id-type="pmid">30580485</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Metry</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Heyer</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hess</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Garzon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Haggstrom</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Frommelt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Adams</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frieden</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Drolet</surname>
                <given-names>B</given-names>
              </name>
              <collab>PHACE Syndrome Research Conference</collab>
            </person-group>
            <article-title>Consensus Statement on Diagnostic Criteria for PHACE Syndrome.</article-title>
            <source>Pediatrics</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>124</volume>
            <issue>5</issue>
            <fpage>1447</fpage>
            <page-range>1447-56</page-range>
            <pub-id pub-id-type="pmid">19858157</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samuelov</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kinori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Kruse</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chamlin</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <article-title>Ocular Complications in PHACE Syndrome: A True Association or a Coincidence?</article-title>
            <source>J Pediatr</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>204</volume>
            <fpage>214</fpage>
            <page-range>214-218.e2</page-range>
            <pub-id pub-id-type="pmid">30270159</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Assari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ziaee</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Moghimi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akbari</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Mirmohammadsadeghi</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>PHACE(S) syndrome: Report of a case with new ocular and systemic manifestations.</article-title>
            <source>J Curr Ophthalmol</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>136</fpage>
            <page-range>136-138</page-range>
            <pub-id pub-id-type="pmid">28626825</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pizzatto</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Resende</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Lobo</surname>
                <given-names>CFT</given-names>
              </name>
              <name>
                <surname>Neves</surname>
                <given-names>YCS</given-names>
              </name>
              <name>
                <surname>Paz</surname>
                <given-names>JAD</given-names>
              </name>
              <name>
                <surname>Alves</surname>
                <given-names>CAPF</given-names>
              </name>
              <name>
                <surname>Leite</surname>
                <given-names>CDC</given-names>
              </name>
              <name>
                <surname>Lucato</surname>
                <given-names>LT</given-names>
              </name>
            </person-group>
            <article-title>Arteriopathy in pediatric stroke: an underestimated clinical entity.</article-title>
            <source>Arq Neuropsiquiatr</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>79</volume>
            <issue>4</issue>
            <fpage>321</fpage>
            <page-range>321-333</page-range>
            <pub-id pub-id-type="pmid">34133513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Winter</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Itinteang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Leadbitter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>ST</given-names>
              </name>
            </person-group>
            <article-title>PHACE syndrome--clinical features, aetiology and management.</article-title>
            <source>Acta Paediatr</source>
            <year>2016</year>
            <month>Feb</month>
            <volume>105</volume>
            <issue>2</issue>
            <fpage>145</fpage>
            <page-range>145-53</page-range>
            <pub-id pub-id-type="pmid">26469095</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dayasiri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Thadchanamoorthy</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>PHACE Syndrome Presenting With Retinal Degeneration, Cortical Dysplasia, Microphthalmia, and Atrial Septal Defect in a South Asian Boy.</article-title>
            <source>Cureus</source>
            <year>2021</year>
            <month>Jan</month>
            <day>26</day>
            <volume>13</volume>
            <issue>1</issue>
            <fpage>e12928</fpage>
            <pub-id pub-id-type="pmid">33654609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27078.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Arvedson</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Bayer</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Drolet</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Chun</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>DH</given-names>
              </name>
            </person-group>
            <article-title>Risk of dysphagia and speech and language delay in PHACE syndrome.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2015</year>
            <season>Jan-Feb</season>
            <volume>32</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-9</page-range>
            <pub-id pub-id-type="pmid">25440893</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
